Top

Intensive Care Medicine

Published in:

01-03-2007 | Pediatric Original

Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children

Authors: Corsino Rey, Marta Los Arcos, Andrés Concha, Alberto Medina, Soledad Prieto, Pablo Martinez, Belen Prieto

Published in: Intensive Care Medicine | Issue 3/2007

Abstract

Objectives

To analyse the clinical value of procalcitonin (PCT), C-reactive protein (CRP) and leucocyte count in the diagnosis of paediatric sepsis and in the stratification of patients according to severity.

Design

Prospective, observational study.

Setting

Paediatric intensive care unit (PICU).

Patients

Ninety-four children.

Measurement and results

Leucocyte count, PCT and CRP were measured when considered necessary during the PICU stay. Patients were classified, when PCT and CRP were measured, into one of six categories (negative, SIRS, localized infection, sepsis, severe sepsis, and septic shock) according to the definitions of the American College of Chest Physicians /Society of Critical Care Medicine. A total of 359 patient day episodes were obtained. Leucocyte count did not differ across the six diagnostic classes considered. Median plasma PCT concentrations were 0.17, 0.43, 0.79, 1.80, 15.40 and 19.13 ng/ml in negative, systemic inflammatory response syndrome (SIRS), localized infection, sepsis, severe sepsis, and septic shock groups, respectively, whereas median plasma CRP concentrations were 1.35, 3.80, 6.45, 5.70, 7.60 and 16.2 mg/dl, respectively. The area under the ROC curve for the diagnosis of septic patients was 0.532 for leucocyte count (95% CI, 0.462–0.602), 0.750 for CRP (95% CI, 0.699–0.802) and 0.912 for PCT (95% CI, 0.882–0.943). We obtained four groups using CRP values and five groups using PCT values that classified a significant percentage of patients according to the severity of the different SIRS groups.

Conclusions

PCT is a better diagnostic marker of sepsis in critically ill children than CRP. The CRP, and especially PCT, may become a helpful clinical tool to stratify patients with SIRS according to disease severity.

Brun-Buisson C (2000) The epidemiology of the systemic inflammatory response. Intensive Care Med 26: (Suppl. 1) S64–S74CrossRef

Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471–1477PubMedCrossRef

Hayden WR (1994) Sepsis terminology in pediatrics. J Pediatr 124:657–658PubMed

Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29:530–538PubMed

Hatherill M, Tibby SM, Sykes K, Turner C, Murdoch IA (1999) Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child 81:417–421PubMedCrossRef

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef

Carcillo JA (2003) Pediatric septic shock and multiple organ failure. Crit Care Clin 19:413–440PubMedCrossRef

Hanley JA, McNeil BA (1982) The meaning and use of the area under a receiver operating (ROC) curve. Radiology 143:29–36PubMed

Goh A, Lum L (1999) Sepsis, severe sepsis and septic shock in paediatric multiple organ dysfunction syndrome. J Paediatr Child Health 35:488–492PubMedCrossRef

10.

Castelli GP, Pognani C, Cita M, Stuani A, Sgarbi L, Paladini R (2006) Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol 72:69–80PubMed

11.

Carrol ED, Newland P, Riordan FA, Thomson AP, Curtis N, Hart CA (2002) Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash. Arch Dis Child 86:282–285PubMedCrossRef

12.

Enguix A, Rey C, Concha A, Medina A, Coto D, Dieguez MA (2001) Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med 27:211–215PubMedCrossRef

13.

Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R (2000) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28:977–983PubMedCrossRef

14.

Povoa P, Almeida E, Moreira P, Fernandes A, Mealha R, Aragao A, Sabino H (1998) C-reactive protein as an indicator of sepsis. Intensive Care Med 24:1052–1056PubMedCrossRef

15.

Suprin E, Camus C, Gacouin A, Le Tulzo Y, Lavoue S, Feuillu A, Thomas R (2000) Procalcitonin: A valuable indicator of infection in a medical ICU? Intensive Care Med 26:1232–1238PubMedCrossRef

16.

Ugarte H, Silva E, Mercan D, Mendonca A de, Vincent JL (1999) Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27:498–504PubMedCrossRef

17.

Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A (2003) Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 31:1737–1741PubMedCrossRef

18.

Geppert A, Steiner A, Delle-Karth G, Heinz G, Huber K (2003) Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med 29:1384–1389PubMedCrossRef

19.

Arkader R, Troster EJ, Lopes MR, Junior RR, Carcillo JA, Leone C, Okay TS (2006) Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. Arch Dis Child 91:117–120PubMedCrossRef

20.

Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY (2006) Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34:1996–2003PubMedCrossRef

21.

Hatherill M, Tibby SM, Turner C, Ratnavel N, Murdoch IA (2000) Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit Care Med 28:2591–2594PubMedCrossRef

22.

Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L (2004) Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 8:R234-R242PubMedCrossRef

23.

Clec'h C, Fosse JP, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y (2006) Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 34:102–107PubMedCrossRef

24.

Celebi S, Koner O, Menda F, Balci H, Hatemi A, Korkut K, Esen F (2006) Procalcitonin kinetics in pediatric patients with systemic inflammatory response after open heart surgery. Intensive Care Med 32:881–887PubMedCrossRef

25.

Meisner M, Tschaikowsky K, Palmaers T, Schmidt J (1999) Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care (Lond) 3:45–50CrossRef

26.

Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164:396–402PubMed

27.

Casado-Flores J, Blanco-Quiros A, Asensio J, Arranz E, Garrote JA, Nieto M (2003) Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count. Pediatr Crit Care Med 4:190–195PubMedCrossRef

28.

Mimoz O, Benoist JF, Edouard AR, Assicot M, Bohuon C, Samii K (1998) Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 24:185–188PubMedCrossRef

29.

Carcillo JA (2004) Mannose-binding lectin deficiency provides a genetic basis for the use of SIRS/sepsis definitions in critically ill patients. Intensive Care Med 30:1263–1265PubMedCrossRef

30.

Trzeciak S, Zanotti-Cavazzoni S, Parrillo JE, Dellinger RP (2005) Inclusion criteria for clinical trials in sepsis: Did the American College of Chest Physicians/Society of Critical Care Medicine consensus conference definitions of sepsis have an impact? Chest 127:242–245PubMedCrossRef

Title: Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children
Authors: Corsino Rey
Marta Los Arcos
Andrés Concha
Alberto Medina
Soledad Prieto
Pablo Martinez
Belen Prieto
Publication date: 01-03-2007
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 3/2007
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-006-0509-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children

Abstract

Objectives

Design

Setting

Patients

Measurement and results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Design

Setting

Patients

Measurement and results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2007

Colistin and rhabdomyolysis: A causative agent or an innocent bystander?

Intensive care outcome of adult patients operated on for congenital heart disease

Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria

Comment on Mackenzie and Woodhouse: C-reactive protein concentrations during bacteraemia: a comparison between patients with and without liver dysfunction

A short goodbye …

Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study

A short goodbye …